UNSPSC 85682057: Removal of bone growth stimulator from facial bone, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of bone growth stimulator from facial bone, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0NPW4MZ

UNSPSC 85682057 Removal of bone growth stimulator from facial bone, percutaneous endoscopic approach is a Commodity code with little relevant recent state and local procurement activity. The code nominally describes a specific surgical procedure, yet the recent opportunities tagged to it instead reflect requests for occupational medical surveillance, independent medical evaluation services, pharmacy benefit management, temporary health professional staffing, surgical benefit carve-out programs, and emergency medical services for youth in custody—none of which involve bone growth stimulator removal or the procedure specified in the code name. The mismatch suggests this code is either rarely used in state and local procurement or has been applied incorrectly to medical and health services contracts that fall outside the narrow surgical-procedure scope the code nominally describes.

The issuing bodies in the recent sample span state departments (Washington State Department of Transportation), counties (Harris County, Collier County, Santa Clara County), and cities (Phoenix, Long Beach), indicating the code appears across diverse jurisdiction types when it does surface. Representative recent opportunities include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026), the Washington State Department of Transportation's RFP for occupational medical surveillance (RFP20260825, due October 9, 2026), and Collier County's RFP for pharmacy benefit management services (RFP 25-8414, originally due April 9, 2026). Geographic spread includes Arizona, Washington, California, Florida, and Texas. The absence of recent solicitations directly tied to the removal of bone growth stimulators from facial bone suggests this Commodity code warrants monitoring rather than active pursuit unless you service hospital surgical departments or physician networks that bill under surgical procedure codes—in which case the tagging misalignment is a signal to verify accurate code placement with issuing bodies before investing bid resources.